BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15106184)

  • 21. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
    Prabhu RA; Nair S; Pai G; Reddy NP; Suvarna D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007003. PubMed ID: 26287983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005527. PubMed ID: 19821346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD007606. PubMed ID: 29630730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
    Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.
    Gurusamy KS; Tsochatzis E; Toon CD; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006573. PubMed ID: 24297303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B.
    Liang N; Kong Z; Lu CL; Ma SS; Li YQ; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013106. PubMed ID: 31232459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud L; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005527. PubMed ID: 16235408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile acids for viral hepatitis.
    Chen W; Liu J; Gluud C
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003181. PubMed ID: 17943781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.
    Iorio A; Marchesini E; Awad T; Gluud LL
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004888. PubMed ID: 20091566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Gluud C
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003620. PubMed ID: 17943794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.
    Liang N; Kong Z; Ma SS; Lu CL; Yang M; Feng LD; Shen C; Diao RH; Cui LJ; Lu XY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013089. PubMed ID: 30941748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Myers RP; Poynard T
    Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.